NexGel Q2 Revenue $3.69M, Net Loss $2.87M; Resolicits Shareholder Approval for Reverse Split
NXGL sits 51% above its 52-week low of $0.33 on elevated volume (5.2× avg).
Summary
NexGel reported Q2 revenue of $3.69 million and a net loss of $2.87 million, with integration challenges and a $795,000 backlog. The company will resolicit shareholder approval for a reverse split and authorized share increase as standalone proposals.
Key Events · Earnings and Guidance · NXGL
-
Q2 Revenue and Loss
Revenue of $3.69 million with a net loss of $2.87 million, including $756,554 in intangible amortization, $273,710 in transaction expenses, and $144,495 for SilverSeal recall.
-
BioNX Surgical Backlog
Supply chain constraints have led to a current BioNX Surgical backlog of approximately $795,000, slowing the integration of the Celularity acquisition.
-
Proxy Resolicitation
The company will resolicit shareholder approval for an authorized share increase and reverse split as standalone proposals, targeting completion in late September 2026.
-
Restricted Cash Released
Approximately $710,000 of restricted cash related to ATW Partners was released and returned to the company, concluding that business relationship.
Analysis · NXGL · Industrial Applications And Services
NexGel's Q2 results show slower-than-expected integration of BioNX Surgical, with a $795,000 backlog and supply chain constraints. The company also disclosed it will resolicit shareholder approval for an authorized share increase and reverse split as standalone proposals after the prior proxy failed due to broker non-votes. This is critical because the company faces a going concern warning and potential defaults on $13.9M in convertible notes, making the capital structure changes essential for survival.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.4% of the 1637 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NXGL was trading at $0.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $0.33 to $2.89. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.